Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.
Hamaguchi T, Tsuji A, Yamaguchi K, Takeda K, Uetake H, Esaki T, Amagai K, Sakai D, Baba H, Kimura M, Matsumura Y, Tsukamoto T. Hamaguchi T, et al. Among authors: tsukamoto t. Cancer Chemother Pharmacol. 2018 Dec;82(6):1021-1029. doi: 10.1007/s00280-018-3693-6. Epub 2018 Oct 4. Cancer Chemother Pharmacol. 2018. PMID: 30284603 Free PMC article. Clinical Trial.
A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma.
Ri M, Suzuki K, Iida S, Hatake K, Chou T, Taniwaki M, Watanabe N, Tsukamoto T. Ri M, et al. Among authors: tsukamoto t. Intern Med. 2018 Apr 1;57(7):939-946. doi: 10.2169/internalmedicine.9567-17. Epub 2017 Dec 8. Intern Med. 2018. PMID: 29225263 Free PMC article. Clinical Trial.
TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer.
Tsutsumi C, Ohuchida K, Tsutsumi H, Shimada Y, Yamada Y, Son K, Hayashida S, Katayama N, Mochida Y, Iwamoto C, Torata N, Horioka K, Shindo K, Mizuuchi Y, Ikenaga N, Nakata K, Ota K, Iwama E, Yamamoto M, Tsukamoto T, Nomura S, Morisaki T, Oda Y, Okamoto I, Nakamura M. Tsutsumi C, et al. Among authors: tsukamoto t. Cancer Lett. 2024 Dec 24;611:217412. doi: 10.1016/j.canlet.2024.217412. Online ahead of print. Cancer Lett. 2024. PMID: 39722406 Free article.
SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study).
Kuwabara T, Miyasato Y, Kanki T, Mizumoto T, Matsubara T, Sawa N, Sugiyama H, Maruyama S, Sato H, Tsukamoto T, Murata T, Miyazaki M, Imasawa T, Mukoyama M, Murakami N, Jhaveri KD, Yanagita M; JSN Onconephrology working group. Kuwabara T, et al. Among authors: tsukamoto t. Clin Kidney J. 2024 Nov 28;17(12):sfae327. doi: 10.1093/ckj/sfae327. eCollection 2024 Dec. Clin Kidney J. 2024. PMID: 39664993 Free PMC article.
Primary large B-cell lymphoma of the central nervous system: A reappraisal of CD5-positive cases based on clinical, pathological, and molecular evaluation.
Yamada S, Satou A, Tsuyuki Y, Iba S, Okumura Y, Ishikawa E, Ito H, Kogure Y, Goto N, Tanikawa M, Shimada K, Tsukamoto T, Karube K, Yokoo H, Kataoka K, Tomita A, Mase M, Nakamura S. Yamada S, et al. Among authors: tsukamoto t. Pathol Int. 2024 Dec 11. doi: 10.1111/pin.13496. Online ahead of print. Pathol Int. 2024. PMID: 39660959
SUSD2+ cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy.
Su R, Sun X, Luo Y, Gu L, Wang F, Dong A, Yamamoto M, Tsukamoto T, Nomura S, Zhao Z, Dai C, Deng G, Zhuang B, He Y, Zhang C, Yin S. Su R, et al. Among authors: tsukamoto t. Gastric Cancer. 2024 Dec 10. doi: 10.1007/s10120-024-01572-9. Online ahead of print. Gastric Cancer. 2024. PMID: 39656339
2,309 results